A Study of KCT-0809 in Patients With Dry Eye Syndromes

Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes

NCT00721656 ·Status: COMPLETED ·Phase: PHASE2

Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

NCT01189032 ·Status: COMPLETED ·Phase: PHASE2

An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

NCT02503176 ·Status: TERMINATED ·Phase: PHASE3

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

NCT04084483 ·Status: COMPLETED ·Phase: PHASE2

Study of OT202 in Treating Moderate to Severe Dry Eye

NCT06435182 ·Status: COMPLETED ·Phase: PHASE2

Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

NCT01101984 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of TOP1630 for Dry Eye Syndrome

NCT03088605 ·Status: COMPLETED ·Phase: PHASE2

Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease

NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease

NCT03216096 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome

NCT02092207 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease

NCT01239069 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease

NCT01562795 ·Status: COMPLETED ·Phase: NA

[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001

NCT05017870 ·Status: COMPLETED ·Phase: PHASE1

An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

NCT07179055 ·Status: RECRUITING ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

NCT04092907 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers

NCT04104997 ·Status: COMPLETED ·Phase: PHASE1

Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome

NCT01670357 ·Status: COMPLETED ·Phase: PHASE2

Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers

NCT01162954 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

NCT02121301 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye

NCT00799552 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

NCT06717152 ·Status: COMPLETED ·Phase: PHASE3

YM-101 Eye Drops in the Treatment of Dry Eye Syndrome

NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1

MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome

NCT07185139 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Study of TOP1630 for Dry Eye Syndrome

NCT03833388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Levocarnitine for Dry Eye in Sjogren's Syndrome

NCT03953703 ·Status: COMPLETED ·Phase: PHASE2